183 related articles for article (PubMed ID: 34714390)
1. Semi-quantitative measurements of chemokine receptor 4-targeted
Pan Q; Cao X; Luo Y; Li J; Li F
EJNMMI Res; 2021 Oct; 11(1):110. PubMed ID: 34714390
[TBL] [Abstract][Full Text] [Related]
2.
Luo Y; Cao X; Pan Q; Li J; Feng J; Li F
J Nucl Med; 2019 Dec; 60(12):1724-1729. PubMed ID: 31101745
[No Abstract] [Full Text] [Related]
3. Chemokine Receptor 4-Targeted 68Ga-Pentixafor PET/CT in Response Assessment of Waldenström Macroglobulinemia/Lymphoplasmacytic Lymphoma: Comparison to 18F-FDG PET/CT.
Pan Q; Cao X; Luo Y; Li J; Li F
Clin Nucl Med; 2021 Sep; 46(9):732-737. PubMed ID: 34172595
[TBL] [Abstract][Full Text] [Related]
4. Chemokine Receptor CXCR4-Targeted PET/CT With 68Ga-Pentixafor Shows Superiority to 18F-FDG in a Patient With Waldenström Macroglobulinemia.
Luo Y; Pan Q; Feng J; Cao X; Li F
Clin Nucl Med; 2018 Jul; 43(7):548-550. PubMed ID: 29742593
[TBL] [Abstract][Full Text] [Related]
5. Different extramedullary disease shown in chemokine receptor 4 targeted PET/CT with [68Ga]Ga-pentixafor in patients with Waldenström macroglobulinemia and smoldering disease.
Pan Q; Cao X; Li J; Li F; Luo Y
Nucl Med Commun; 2024 May; ():. PubMed ID: 38745523
[TBL] [Abstract][Full Text] [Related]
6. Chemokine receptor-4 targeted PET/CT with
Pan Q; Cao X; Luo Y; Li J; Feng J; Li F
Eur J Nucl Med Mol Imaging; 2020 Mar; 47(3):537-546. PubMed ID: 31776631
[TBL] [Abstract][Full Text] [Related]
7. Chemokine receptor-targeted PET/CT provides superior diagnostic performance in newly diagnosed marginal zone lymphoma patients: a head-to-head comparison with [
Kosmala A; Duell J; Schneid S; Serfling SE; Higuchi T; Weich A; Lapa C; Hartrampf PE; Raderer M; Einsele H; Buck AK; Topp MS; Schlötelburg W; Werner RA
Eur J Nucl Med Mol Imaging; 2024 Feb; 51(3):749-755. PubMed ID: 37943339
[TBL] [Abstract][Full Text] [Related]
8. CXCR4-Directed PET/CT with [
Chen Z; Yang A; Zhang J; Chen A; Zhang Y; Huang C; Chen S; Yao S; Miao W
Mol Imaging Biol; 2022 Jun; 24(3):416-424. PubMed ID: 34651291
[TBL] [Abstract][Full Text] [Related]
9. Preliminary evidence of imaging of chemokine receptor-4-targeted PET/CT with [
Pan Q; Luo Y; Zhang Y; Chang L; Li J; Cao X; Li J; Li F
EJNMMI Res; 2020 Aug; 10(1):89. PubMed ID: 32757068
[TBL] [Abstract][Full Text] [Related]
10. Imaging Inflammation in Atherosclerosis with CXCR4-Directed
Kircher M; Tran-Gia J; Kemmer L; Zhang X; Schirbel A; Werner RA; Buck AK; Wester HJ; Hacker M; Lapa C; Li X
J Nucl Med; 2020 May; 61(5):751-756. PubMed ID: 31653710
[TBL] [Abstract][Full Text] [Related]
11. Bing-Neel Syndrome and Coexisting Pituitary Macroadenoma in a Patient with Waldenström Macroglobulinemia Revealed by
Pan Q; Luo Y; Cao X; Li J; Feng J
Diagnostics (Basel); 2023 Apr; 13(7):. PubMed ID: 37046551
[TBL] [Abstract][Full Text] [Related]
12. The Role of [
Albano D; Dondi F; Bertagna F; Treglia G
Cancers (Basel); 2022 Aug; 14(15):. PubMed ID: 35954476
[TBL] [Abstract][Full Text] [Related]
13. Prognostic significance of
Kuyumcu S; Isik EG; Tiryaki TO; Has-Simsek D; Sanli Y; Buyukkaya F; Özkan ZG; Kalayoglu-Besisik S; Unal SN
Ann Nucl Med; 2021 Oct; 35(10):1147-1156. PubMed ID: 34185263
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic efficacy of C-X-C motif chemokine receptor 4-directed PET/CT in newly diagnosed head and neck squamous cell carcinoma - a head-to-head comparison with [
Zhi Y; Werner RA; Schirbel A; Higuchi T; Buck AK; Kosmala A; Bley TA; Hagen R; Hackenberg S; Rosenwald A; Scherzad A; Gerhard-Hartmann E; Serfling SE
Am J Nucl Med Mol Imaging; 2023; 13(5):208-216. PubMed ID: 38023816
[TBL] [Abstract][Full Text] [Related]
15. (68)Ga-Pentixafor-PET/CT for Imaging of Chemokine Receptor 4 Expression in Glioblastoma.
Lapa C; Lückerath K; Kleinlein I; Monoranu CM; Linsenmann T; Kessler AF; Rudelius M; Kropf S; Buck AK; Ernestus RI; Wester HJ; Löhr M; Herrmann K
Theranostics; 2016; 6(3):428-34. PubMed ID: 26909116
[TBL] [Abstract][Full Text] [Related]
16. Investigating the Chemokine Receptor 4 as Potential Theranostic Target in Adrenocortical Cancer Patients.
Bluemel C; Hahner S; Heinze B; Fassnacht M; Kroiss M; Bley TA; Wester HJ; Kropf S; Lapa C; Schirbel A; Buck AK; Herrmann K
Clin Nucl Med; 2017 Jan; 42(1):e29-e34. PubMed ID: 27819856
[TBL] [Abstract][Full Text] [Related]
17. Comparison of [
Liu M; Chen X; Ding H; Shu Q; Zheng Y; Chen Y; Cai L
Mol Imaging Biol; 2024 Apr; ():. PubMed ID: 38627276
[TBL] [Abstract][Full Text] [Related]
18. [
Lapa C; Schreder M; Schirbel A; Samnick S; Kortüm KM; Herrmann K; Kropf S; Einsele H; Buck AK; Wester HJ; Knop S; Lückerath K
Theranostics; 2017; 7(1):205-212. PubMed ID: 28042328
[TBL] [Abstract][Full Text] [Related]
19. CXCR4-Directed Imaging in Solid Tumors.
Werner RA; Kircher S; Higuchi T; Kircher M; Schirbel A; Wester HJ; Buck AK; Pomper MG; Rowe SP; Lapa C
Front Oncol; 2019; 9():770. PubMed ID: 31475113
[TBL] [Abstract][Full Text] [Related]
20. [
Lawal IO; Popoola GO; Mahapane J; Kaufmann J; Davis C; Ndlovu H; Maserumule LC; Mokoala KMG; Bouterfa H; Wester HJ; Zeevaart JR; Sathekge MM
Biomolecules; 2020 Dec; 10(12):. PubMed ID: 33287237
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
